PACB
Pacific Biosciences Of California Stock Analysis
AI Rating
- Quality1/10
- Growth↓ 2/10
- Value↓ 0/10
PACB Growth
- Revenue Y/Y↓ 3.89%
- EPS Y/Y↓ -61.06%
- FCF Y/Y↑ 46.33%
PACB Profitability
- Gross margin ↑ 28.60%
- EPS margin↓ -341.50%
- ROIC 5Y↓ -30.98%
PACB Risk
- Debt / Equity↑ 131.3
- Debt / FCF↑ 5.6
- Interest coverage↓ -77.5
Pacific Biosciences Of California stock volatility is higher than the overall market. We give it a Poor risk rating.